Home> Products> tp mate 50 therapy

{ "products": [ { "_id": "666c09b805b00e1ad41ca790", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TP MATE 50 ", "description": "TP MATE 50 \nTopiramate (50mg)\nIntroduction:\n\nTP MATE 50 contains Topiramate, a versatile anticonvulsant and migraine prophylactic medication. With a dosage strength of 50mg, TP MATE 50 is designed to manage seizures in epilepsy and prevent migraines, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nTP MATE 50 is highly effective in treating various types of seizures, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It stabilizes neuronal activity by enhancing GABAergic transmission, blocking sodium channels, and inhibiting glutamate activity.\nMigraine Prophylaxis:\n\nTopiramate is widely used for preventing migraines. By modulating neurotransmitter activity, TP MATE 50 reduces the frequency and severity of migraine attacks, helping patients manage their condition and improve their daily functioning.\nWeight Management:\n\nAn added benefit of TP MATE 50 is its potential to assist with weight loss. Unlike many anticonvulsants, Topiramate may lead to weight reduction, which can be beneficial for patients concerned about weight gain associated with other medications.\nMood Stabilization:\n\nTopiramate has mood-stabilizing properties, making it useful for patients with coexisting mood disorders such as bipolar disorder. It helps in stabilizing mood swings and reducing symptoms of anxiety and depression.\nWell-Tolerated and Safe:\n\nTP MATE 50 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and migraines.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of TP MATE 50 for adults with epilepsy typically starts at a low dose, gradually increasing to reduce the risk of side effects. A common starting dose is 25-50mg per day, increasing weekly by 25-50mg until the effective dose is reached. The usual maintenance dose ranges from 200-400mg per day, divided into two doses.\nInitial Dosage for Migraine Prophylaxis:\n\nFor migraine prevention, the initial dose is 25mg taken once daily, usually at night. The dose may be increased weekly by 25mg, up to a recommended dose of 50-100mg per day, divided into two doses.\nAdministration Instructions:\n\nTP MATE 50 tablets should be taken orally with or without food. It is important to maintain consistent dosing schedules to ensure stable therapeutic levels.\nContinued Monitoring:\n\nRegular monitoring of seizure frequency, migraine attacks, and potential side effects is essential during TP MATE 50 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tp-mate-50-133634", "price": 99.0, "discountamount": 29.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "50mg", "25mg", "risk", "EMAIL", "night", "option", "adults", "anxiety", "quality", "symptoms", "severity", "50-100mg", "low dose", "epilepsy", "patients", "Benefits", "200-400mg", "two doses", "condition", "migraines", "Topiramate", "depression", "mood swings", "weight gain", "weight loss", "information", "Key Features", "sterispharma", "Introduction", "initial dose", "sterisonline", "CALL/WHATSAPP", "added benefit", "various types", "mood disorders", "patient safety", "Initial Dosage", "effective dose", "sodium channels", "dosage strength", "migraine attacks", "bipolar disorder", "weight reduction", "neuronal activity", "seizure frequency", "daily functioning", "other medications", "Weight Management", "Regular monitoring", "Mood Stabilization", "TP MATE 50 therapy", "glutamate activity", "TP MATE 50 tablets", "migraine prevention", "long-term management", "Migraine Prophylaxis", "Continued Monitoring", "common starting dose", "many anticonvulsants", "therapeutic efficacy", "Anticonvulsant Action", "usual maintenance dose", "potential side effects", "partial-onset seizures", "GABAergic transmission", "Lennox-Gastaut syndrome", "favorable safety profile", "versatile anticonvulsant", "neurotransmitter activity", "stable therapeutic levels", "Administration Instructions", "mood-stabilizing properties", "consistent dosing schedules", "migraine prophylactic medication", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1905, "imageuri": "https://productimages.withfloats.com/actual/666c09bbf068be46bdec8995.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c09bbf068be46bdec8995.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:13:28.046Z", "updatedon": "2024-06-26T06:01:34.175Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tp-mate-50-/1905", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TP MATE 50 ", "category": "NEUROLOGY RANGE", "tags": [ "TP MATE 50", "", "Topiramate (50mg)", "topiramate uses", "topiramate 50 mg", "topiramate side effects", "topiramate side effects weight loss" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e7a474f3481c1f16d3b038", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)", "description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2185, "imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-09T12:03:00.012Z", "updatedon": "2025-10-09T12:03:00.012Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-10-02T11:20:20.402Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b02393f5434d48fca8b8ca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 50", "description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2165, "imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:38:27.036Z", "updatedon": "2025-08-28T09:38:27.036Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 50 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c1007162db0236048bac5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 500 ", "description": "VALPOTREAT CR 500 \nSodium Valproate CR 500 mg\nIntroduction:\n\nVALPOTREAT CR 500 contains Sodium Valproate, a potent anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 500mg, VALPOTREAT CR 500 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 500 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 500 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 500 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 500 for adults typically starts at 500mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 500mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 500 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 500 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/valpotreat-cr-500-134217", "price": 121.18, "discountamount": 36.35, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "food", "time", "need", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "epilepsy", "severity", "patients", "Benefits", "frequency", "two doses", "adherence", "medication", "mood swings", "information", "initial dose", "GABA) levels", "tolerability", "sterispharma", "Key Features", "Introduction", "sterisonline", "various types", "CALL/WHATSAPP", "liver function", "Initial Dosage", "patient safety", "overall health", "manic episodes", "steady release", "mood stability", "mood stabilizer", "symptom control", "frequent dosing", "dosage strength", "seizure episodes", "absence seizures", "bipolar disorder", "treatment regimen", "clinical response", "neuronal activity", "Mood Stabilization", "Regular monitoring", "Sodium Valproate CR", "Continued Monitoring", "long-term management", "therapeutic efficacy", "Anticonvulsant Action", "potent anticonvulsant", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "favorable safety profile", "complex partial seizures", "typical maintenance dose", "VALPOTREAT CR 500 therapy", "VALPOTREAT CR 500 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1909, "imageuri": "https://productimages.withfloats.com/actual/666c100b8c6c791fd3b72fe4.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c100b8c6c791fd3b72fe4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:40:23.921Z", "updatedon": "2024-06-26T05:53:21.154Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-500-/1909", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 500 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 500 mg", "VALPOTREAT CR 500", "", "VALPOTREAT CR 500 price", "", "valprol cr 500 uses and side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c08e7c91739182c9574b6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TP MATE 100 ", "description": "TP MATE 100 \nTopiramate (100mg)\nIntroduction:\n\nTP MATE 100 contains Topiramate, a broad-spectrum anticonvulsant and migraine prophylactic medication. With a dosage strength of 100mg, TP MATE 100 is designed to manage seizures in epilepsy and prevent migraines, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nTP MATE 100 is highly effective in treating various types of seizures, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It stabilizes neuronal activity by enhancing GABAergic transmission, blocking sodium channels, and inhibiting glutamate activity.\nMigraine Prophylaxis:\n\nTopiramate is widely used for preventing migraines. By modulating neurotransmitter activity, TP MATE 100 reduces the frequency and severity of migraine attacks, helping patients manage their condition and improve their daily functioning.\nWeight Management:\n\nAn added benefit of TP MATE 100 is its potential to assist with weight loss. Unlike many anticonvulsants, Topiramate may lead to weight reduction, which can be beneficial for patients concerned about weight gain associated with other medications.\nMood Stabilization:\n\nTopiramate has mood-stabilizing properties, making it useful for patients with coexisting mood disorders such as bipolar disorder. It helps in stabilizing mood swings and reducing symptoms of anxiety and depression.\nWell-Tolerated and Safe:\n\nTP MATE 100 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and migraines.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of TP MATE 100 for adults with epilepsy typically starts at a low dose, gradually increasing to reduce the risk of side effects. A common starting dose is 25-50mg per day, increasing weekly by 25-50mg until the effective dose is reached. The usual maintenance dose ranges from 200-400mg per day, divided into two doses.\nInitial Dosage for Migraine Prophylaxis:\n\nFor migraine prevention, the initial dose is 25mg taken once daily, usually at night. The dose may be increased weekly by 25mg, up to a recommended dose of 100mg per day, divided into two doses.\nAdministration Instructions:\n\nTP MATE 100 tablets should be taken orally with or without food. It is important to maintain consistent dosing schedules to ensure stable therapeutic levels.\nContinued Monitoring:\n\nRegular monitoring of seizure frequency, migraine attacks, and potential side effects is essential during TP MATE 100 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tp-mate-100-133633", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "25mg", "risk", "50mg", "EMAIL", "night", "100mg", "option", "adults", "anxiety", "quality", "symptoms", "severity", "low dose", "epilepsy", "patients", "Benefits", "200-400mg", "two doses", "condition", "migraines", "Topiramate", "depression", "mood swings", "weight gain", "weight loss", "information", "Key Features", "sterispharma", "Introduction", "initial dose", "sterisonline", "CALL/WHATSAPP", "added benefit", "various types", "mood disorders", "patient safety", "Initial Dosage", "effective dose", "sodium channels", "dosage strength", "migraine attacks", "bipolar disorder", "weight reduction", "neuronal activity", "seizure frequency", "daily functioning", "other medications", "Weight Management", "Regular monitoring", "Mood Stabilization", "glutamate activity", "migraine prevention", "TP MATE 100 therapy", "TP MATE 100 tablets", "long-term management", "Migraine Prophylaxis", "Continued Monitoring", "common starting dose", "many anticonvulsants", "therapeutic efficacy", "Anticonvulsant Action", "usual maintenance dose", "potential side effects", "partial-onset seizures", "GABAergic transmission", "Lennox-Gastaut syndrome", "favorable safety profile", "neurotransmitter activity", "stable therapeutic levels", "Administration Instructions", "mood-stabilizing properties", "consistent dosing schedules", "broad-spectrum anticonvulsant", "migraine prophylactic medication", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1904, "imageuri": "https://productimages.withfloats.com/actual/666c08eb0b4fc76a99a41986.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c08eb0b4fc76a99a41986.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:09:59.43Z", "updatedon": "2024-06-26T06:09:24.07Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tp-mate-100-/1904", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TP MATE 100 ", "category": "NEUROLOGY RANGE", "tags": [ "tp mate 100 tablet price", "topiramate side effects weight loss", "topiramate side effects", "tp mate 100 tablet in hindi language" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c07d66641561b044696cc", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TARPEDO ER 50 ", "description": "TARPEDO ER 50 \nTapentadol HCL ER Tablets, (50mg)\nIntroduction:\n\nTARPEDO ER 50 contains Tapentadol HCL, an extended-release (ER) formulation designed for the management of moderate to severe chronic pain. With a dosage strength of 50mg, TARPEDO ER 50 provides sustained pain relief, improving the quality of life for patients who require long-term pain management.\nKey Features and Benefits:\n\nDual Mechanism of Action:\n\nOpioid Agonist: Tapentadol acts as a mu-opioid receptor agonist, providing potent analgesic effects by altering the perception of pain in the central nervous system.\nNorepinephrine Reuptake Inhibitor: It also inhibits the reuptake of norepinephrine, enhancing pain inhibition in the brain and spinal cord, contributing to its analgesic properties.\nExtended-Release Formulation:\n\nTARPEDO ER 50 is designed for extended release, ensuring a steady release of medication over a 12-hour period. This provides consistent pain control and reduces the need for frequent dosing.\nEffective Pain Management:\n\nSuitable for managing various types of chronic pain, including neuropathic pain, osteoarthritis, and lower back pain. TARPEDO ER 50 helps patients maintain daily activities and improve their overall quality of life.\nReduced Side Effects:\n\nCompared to other opioids, Tapentadol has a lower incidence of common opioid-related side effects such as nausea, vomiting, and constipation, making it a more tolerable option for long-term use.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended starting dose of TARPEDO ER 50 is 50mg twice daily, approximately every 12 hours. Dosage should be adjusted based on individual patient response and tolerability.\nTitration and Maintenance:\n\nThe dose may be increased in increments of 50mg every 3 days as needed to achieve adequate pain control. The maximum recommended dose is 500mg per day.\nAdministration Instructions:\n\nSwallow TARPEDO ER 50 tablets whole with water. Do not crush, chew, or split the tablets to avoid rapid release of the drug, which can increase the risk of adverse effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tarpedo-er-50-133971", "price": 148.0, "discountamount": 44.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "50mg", "life", "risk", "drug", "need", "Order", "EMAIL", "water", "500mg", "brain", "Action", "nausea", "option", "patients", "Benefits", "vomiting", "12 hours", "Titration", "medication", "perception", "increments", "information", "Maintenance", "spinal cord", "moderate to", "Introduction", "sterispharma", "sterisonline", "constipation", "tolerability", "Key Features", "CALL/WHATSAPP", "rapid release", "starting dose", "other opioids", "various types", "long-term use", "12-hour period", "osteoarthritis", "Initial Dosage", "Opioid Agonist", "steady release", "Dual Mechanism", "lower back pain", "pain inhibition", "lower incidence", "adverse effects", "overall quality", "dosage strength", "frequent dosing", "neuropathic pain", "daily activities", "extended release", "severe chronic pain", "analgesic properties", "Reduced Side Effects", "sustained pain relief", "adequate pain control", "central nervous system", "consistent pain control", "potent analgesic effects", "maximum recommended dose", "long-term pain management", "Tapentadol HCL ER Tablets", "Effective Pain Management", "mu-opioid receptor agonist", "individual patient response", "Administration Instructions", "Extended-Release Formulation", "Swallow TARPEDO ER 50 tablets", "Norepinephrine Reuptake Inhibitor", "extended-release (ER) formulation", "common opioid-related side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1903, "imageuri": "https://productimages.withfloats.com/actual/666c07da0b4fc76a99a41803.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c07da0b4fc76a99a41803.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:05:26.681Z", "updatedon": "2024-06-26T06:23:02.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tarpedo-er-50-/1903", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TARPEDO ER 50 ", "category": "NEUROLOGY RANGE", "tags": [ "TARPEDO ER 50", "", "Tapentadol HCL ER Tablets, (50mg)", "", "tapentadol 50 mg side effects", "long-term side effects of tapentadol" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c03124cb45413344ec7be", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SUMATROPH 50 ", "description": "SUMATROPH 50 \nSumatriptan succinate Rapid- Release (50mg)\nIntroduction:\n\nSUMATROPH 50 contains Sumatriptan succinate, a selective serotonin receptor agonist (triptan) used for the acute treatment of migraine attacks. With a dosage strength of 50mg in a rapid-release formulation, SUMATROPH 50 offers quick and effective relief from the debilitating symptoms of migraines, helping patients regain control over their daily lives.\nKey Features and Benefits:\n\nRapid-Release Formulation:\n\nSUMATROPH 50 is designed to provide rapid relief from migraine symptoms. Its quick absorption and onset of action help alleviate headache pain, nausea, and sensitivity to light and sound within a short period.\nTargeted Action:\n\nSumatriptan succinate specifically targets serotonin (5-HT1) receptors in the brain, leading to the constriction of dilated blood vessels, which is believed to be a primary cause of migraine pain. This targeted action effectively reduces the intensity and duration of migraine attacks.\nSymptom Relief:\n\nSUMATROPH 50 not only alleviates headache pain but also helps relieve associated migraine symptoms such as nausea, vomiting, and photophobia (sensitivity to light) or phonophobia (sensitivity to sound), providing comprehensive symptom relief.\nImproved Quality of Life:\n\nBy providing quick and effective relief from migraines, SUMATROPH 50 enables patients to resume their daily activities with minimal disruption, enhancing their overall quality of life.\nWell-Tolerated and Safe:\n\nSumatriptan is generally well-tolerated, with a favorable safety profile, making SUMATROPH 50 a reliable option for the acute treatment of migraines.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended dose of SUMATROPH 50 for adults is 50mg taken orally at the first sign of a migraine attack. The dose may be increased to 100mg if needed, based on individual response and tolerability.\nMaximum Dosage:\n\nDo not exceed 200mg in a 24-hour period. If the migraine returns after initial relief, a second dose may be taken at least 2 hours after the first dose.\nAdministration Instructions:\n\nSwallow SUMATROPH 50 tablets whole with water. The rapid-release formulation ensures quick absorption and onset of action.\nContinued Monitoring:\n\nRegular monitoring of migraine frequency, severity, and response to treatment is essential to optimize therapy and ensure patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/sumatroph-50-133683", "price": 148.4, "discountamount": 44.52, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Life", "50mg", "light", "100mg", "onset", "sound", "brain", "200mg", "Order", "water", "EMAIL", "adults", "nausea", "option", "therapy", "control", "duration", "severity", "patients", "vomiting", "Benefits", "intensity", "migraines", "first sign", "first dose", "sensitivity", "second dose", "photophobia", "daily lives", "phonophobia", "information", "constriction", "Introduction", "sterisonline", "tolerability", "Key Features", "short period", "rapid relief", "sterispharma", "primary cause", "headache pain", "CALL/WHATSAPP", "migraine pain", "patient safety", "24-hour period", "Initial Dosage", "Maximum Dosage", "initial relief", "acute treatment", "dosage strength", "Targeted Action", "overall quality", "effective relief", "quick absorption", "Improved Quality", "daily activities", "migraine attacks", "minimal disruption", "Regular monitoring", "migraine frequency", "individual response", "Continued Monitoring", "debilitating symptoms", "dilated blood vessels", "favorable safety profile", "rapid-release formulation", "serotonin (5-HT1) receptors", "Administration Instructions", "Swallow SUMATROPH 50 tablets", "associated migraine symptoms", "comprehensive symptom relief", "Sumatriptan succinate Rapid- Release", "selective serotonin receptor agonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1900, "imageuri": "https://productimages.withfloats.com/actual/666c03182d43284d72746dc6.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c03182d43284d72746dc6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T08:45:06.277Z", "updatedon": "2024-06-29T12:24:49.64Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sumatroph-50-/1900", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SUMATROPH 50 ", "category": "NEUROLOGY RANGE", "tags": [ "SUMATROPH 50", "", "sumatriptan 50 mg tablet uses", "Sumatriptan succinate Rapid- Release (50mg)", "sumatriptan side effects", "sumatriptan 50 mg tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666acb47aebebd0900164cc8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "OXCARBZEN 150 ", "description": "OXCARBZEN 150 \nOxcarbazepine IP (150mg)\nIntroduction:\n\nOXCARBZEN 150 contains Oxcarbazepine IP (150 mg), an antiepileptic medication used to manage and treat partial seizures in epilepsy. Oxcarbazepine works by stabilizing the electrical activity in the brain, preventing the excessive electrical discharges that cause seizures.\nKey Features and Benefits:\n\nSeizure Control: Oxcarbazepine effectively reduces the frequency and severity of partial seizures, improving the quality of life for individuals with epilepsy.\nMood Stabilization: Besides its antiepileptic properties, Oxcarbazepine has mood-stabilizing effects, making it beneficial for individuals with mood disorders associated with epilepsy.\nWell-Tolerated: Generally well-tolerated with a favorable side effect profile compared to other antiepileptic medications.\nOnce-Daily Dosing: The 150 mg dosage allows for flexible dosing schedules, making it easier for patients to adhere to their treatment regimen.\nProven Efficacy: Oxcarbazepine is a well-established medication with a strong track record of efficacy and safety in treating epilepsy.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of OXCARBZEN 150 is 300 mg per day, divided into two doses. The dosage may be gradually increased by a healthcare provider based on the patient's response to treatment and the severity of seizures.\nMaintenance Dosage: The usual maintenance dose ranges from 600 mg to 2400 mg per day, divided into two doses, depending on the patient's needs and response to therapy.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Oxcarbazepine at the same time each day to maintain consistent medication levels in the bloodstream.\nMissed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not take a double dose to make up for a missed one.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/oxcarbzen-150-133598", "price": 89.0, "discountamount": 26.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "life", "EMAIL", "water", "needs", "brain", "600 mg", "300 mg", "tablet", "safety", "quality", "2400 mg", "therapy", "patients", "Benefits", "epilepsy", "severity", "response", "next dose", "OXCARBZEN", "same time", "two doses", "frequency", "individuals", "bloodstream", "information", "double dose", "Key Features", "Daily Dosing", "Introduction", "sterispharma", "sterisonline", "150 mg dosage", "CALL/WHATSAPP", "Administration", "Initial Dosage", "mood disorders", "Seizure Control", "Proven Efficacy", "Oxcarbazepine IP", "regular schedule", "partial seizures", "treatment regimen", "Mood Stabilization", "Maintenance Dosage", "strong track record", "electrical activity", "healthcare provider", "typical starting dose", "usual maintenance dose", "mood-stabilizing effects", "antiepileptic properties", "flexible dosing schedules", "consistent medication levels", "favorable side effect profile", "other antiepileptic medications", "excessive electrical discharges" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1868, "imageuri": "https://productimages.withfloats.com/actual/667d3e71422dd0be26725b50.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3e71422dd0be26725b50.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T10:34:47.944Z", "updatedon": "2024-06-27T10:26:51.75Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/oxcarbzen-150-/1868", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OXCARBZEN 150 ", "category": "NEUROLOGY RANGE", "tags": [ "OXCARBZEN 150", "Oxcarbazepine IP (150mg)", "", "oxcarbazepine uses", "oxcarbazepine 300 mg tablet uses", "oxcarbazepine 150 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }